Peter Kufer

This inventor holds 65 USPTO granted patents and 42 published patent applications, plus 19 CIPO patents and 41 EPO patents, primarily in Bispecific Antibody Constructs (CPC class C07K). Top assignees: Amgen Research (Munich) Gmbh, Amgen Inc., Micromet Ag. Active years: 2002-2026.

USPTO Granted Patents = 65 (Patent Applications = 42)

% Patents Active = 95.4

CIPO Patents = 19 (Patent Applications = 8)

EPO Patents = 41 (Patent Applications = 53)

Average Co-Inventor Count = 6.2

ph-index = 17

Forward Citations = 1,071(Granted Patents)

Forward Citations (Not Self Cited) = 908(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Münich, DE (2017)
Moosburg, DE (2002 - 2021)
Moosburg an der Isar, DE (2022)
Munich, DE (2007 - 2024)

Company Filing History:

49 out of 77

Amgen Research (Munich) Gmbh

Boehringer Ingelheim International Gmbh

patents

5. 1 out of 1

Micromet Gesellschaft Fur Biomedizinische Forschung Mbh

where one patent can have more than one assignee

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

CD3 Binding

BCMA

DLL3

CDH19

EGFRVIII

T Cell Engaging

Cross-Species Specific

Single Chain Antibodies

Nucleic Acids

Cancer Treatment

Antibody Constructs

65 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735484 - Bispecific single chain antibodies with specificity for high molecular weight target antigens (2026-09-15),

2. 12441796 - Antibody constructs for CDH19 and CD3 (2025-10-14),

3. 12435139 - Antibody constructs for DLL3 and CD3 (2025-10-07),

4. 12428491 - PSMA and CD3 bispecific T cell engaging antibody constructs (2025-09-30),

5. 12304952 - Antibody constructs for DLL3 and CD3 (2025-05-20),

6. 12297292 - Antibody constructs for CDH19 and CD3 (2025-05-13),

7. 12281176 - Binding molecules for BCMA and CD3 (2025-04-21),

8. 12281175 - Binding molecules for BCMA and CD3 (2025-04-21),

9. 12281172 - Cross-species-specific PSMAxCD3 bispecific single chain antibody (2025-04-21),

10. 12152078 - Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3 (2024-11-26),

11. 11987633 - Cross-species-specific single domain bispecific single chain antibody (2024-05-21),

12. 11926666 - Bispecific antibody constructs for CDH3 and CD3 (2024-03-12),

13. 11925684 - Compositions comprising cross-species-specific antibodies and uses thereof (2024-03-12),

14. 11884720 - Antibody constructs for MSLN and CD3 (2024-01-30),

15. 11661462 - Optimized cross-species specific bispecific single chain antibody contructs (2023-05-30),

Title: The Innovative Journey of Peter Kufer

Introduction: Peter Kufer, a visionary inventor hailing from Munich, Germany, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Peter Kufer's latest patents include a cutting-edge smart home automation system that revolutionizes the way we interact with our living spaces, and a sustainable energy solution that aims to tackle environmental challenges.

Career Highlights: With a career spanning over two decades, Peter Kufer has established himself as a pioneer in the tech industry. His early work focused on developing advanced robotics for industrial applications, leading to several patents in the field.

Collaborations: Throughout his career, Peter Kufer has collaborated with leading tech companies and research institutions to bring his ideas to life. His partnerships have resulted in the successful commercialization of several innovative products.

Conclusion: Peter Kufer's relentless passion for innovation and his commitment to pushing the boundaries of technology have solidified his reputation as a trailblazing inventor in the industry. His work continues to inspire future generations of inventors to think outside the box and create solutions that shape the world of tomorrow.